Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
Contributed to almost 61% of FDA approved NMEs from 2017/19
Work with top 25 BioPharma companies
Latest from Almac
Partnering to advance human healthExplore our locations
Almac Discovery is an independent, research driven drug discovery company dedicated to the development of novel and innovative therapeutics. Our multidisciplinary team of scientists use cutting edge research techniques to develop First in Class preclinical stage assets. Key research themes include protein homeostasis (specifically focused on deubiquitinase enzymes) and next generation protein drug conjugates.Find out more
Innovations in Synthesis: Advancing Capabilities and Empowering Industrial Processes
10 July 2022 Manchester, NH
Organic Reactions and Processes Gordon Research Conference
17 July 2022 Bryant University, Smithfield, RI United States
BIO Asia-Taiwan 2022
28 July 2022 Taipei Nangang Exhibition Center, Taiwan